Low-ogestrel Kit
Product Images NDC 51862-564

6 FDA label images from Mayne Pharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Low-ogestrel (NDC 51862-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lowogestrel 01)

Chemical Structure (Lowogestrel 01)
Chemical structure diagram showing the molecular structure of the active ingredient in Low-Ogestrel, featuring a steroid backbone with labeled functional groups including hydroxyl (OH), ethyl (C2H5), and an alkyne group (C≡CH).*
FDA Label Image

Chemical Structure (Lowogestrel 02)

Chemical Structure (Lowogestrel 02)
Chemical structure diagram showing a molecular formula with a steroid backbone and an ethynyl group. This likely represents the chemical structure of Ethinyl Estradiol, a component of the Low-Ogestrel kit containing Norgestrel and Ethinyl Estradiol by Mayne Pharma Inc.*
FDA Label Image

Figure 1 (Lowogestrel 02a)

Figure 1 (Lowogestrel 02a)
A forest plot titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates from multiple studies comparing breast cancer risk with combined oral contraceptive use versus never use. The horizontal axis represents the effect estimate ranging from negative to positive values, with studies listed on the left and odds ratios, relative risks, and hazard ratios provided on the right. Each study's estimate is displayed as a point with confidence intervals.*
FDA Label Image

Image (Lowogestrel 03)

Image (Lowogestrel 03)
A vertical chart illustrating pregnancy rates associated with various birth control methods. The chart ranks methods from fewest pregnancies (fewer than 1 per 100 women per year) at the top, including implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, and vaginal ring with hormones; to more pregnancies (85 or more per 100 women per year) at the bottom with no birth control. Intermediate methods such as condoms and diaphragms, and less effective methods like abstinence during fertile days, spermicide, and withdrawal are also listed.*
FDA Label Image

Image (Lowogestrel 04)

Image (Lowogestrel 04)
An instructional diagram for the Low-Ogestrel kit (Norgestrel and Ethinyl Estradiol) showing a weekly pill-taking schedule from Sunday through Saturday. It displays four rows of circular pill slots with arrows guiding the user through the sequence. The last week is labeled as inactive tablets. The label includes the product name and NDC 51862-564-01.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Low-Ogestrel kit packaging label for tablets containing norgestrel 0.3 mg and ethinyl estradiol 0.03 mg. The package includes 6 blister cards with 28 tablets each, featuring a 28-day regimen. Distributed by Mayne Pharma Inc., the label indicates prescription use only and storage instructions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.